Roth JS - Search Results

1

A pediatric phase I and pharmacokinetic study of spirohydantoin mustard.

Heideman RL, Kelley JA, Packer RJ, Reaman GH, Roth JS, Balis F, Ettinger LJ, Doherty KM, Jeffries SL, Poplack DG. Heideman RL, et al. Among authors: roth js. Cancer Res. 1988 Apr 15;48(8):2292-5. Cancer Res. 1988. PMID: 3349492

2

The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.

Kelley JA, Litterst CL, Roth JS, Vistica DT, Poplack DG, Cooney DA, Nadkarni M, Balis FM, Broder S, Johns DG. Kelley JA, et al. Among authors: roth js. Drug Metab Dispos. 1987 Sep-Oct;15(5):595-601. Drug Metab Dispos. 1987. PMID: 2891473

3

Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid.

Collins JM, Klecker RW Jr, Kelley JA, Roth JS, McCully CL, Balis FM, Poplack DG. Collins JM, et al. Among authors: roth js. J Pharmacol Exp Ther. 1988 May;245(2):466-70. J Pharmacol Exp Ther. 1988. PMID: 3367302

4

2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.

Roth JS, McCully CM, Balis FM, Poplack DG, Kelley JA. Roth JS, et al. Drug Metab Dispos. 1999 Oct;27(10):1128-32. Drug Metab Dispos. 1999. PMID: 10497138

5

Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.

Ward FT, Kelley JA, Roth JS, Lombardo FA, Weiss RB, Leyland-Jones B, Chun HG. Ward FT, et al. Among authors: roth js. Cancer Res. 1991 Apr 1;51(7):1803-10. Cancer Res. 1991. PMID: 2004365 Clinical Trial.

6

A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880).

Curt GA, Kelley JA, Fine RL, Huguenin PN, Roth JS, Batist G, Jenkins J, Collins JM. Curt GA, et al. Among authors: roth js. Cancer Res. 1985 Jul;45(7):3359-63. Cancer Res. 1985. PMID: 2408749

7

Spiromustine analogues. Relationships between structure, plasma stability, and antitumor activity.

Haces A, Driscoll JS, Roth JS, Heideman RL, Kelley JA. Haces A, et al. Among authors: roth js. J Pharm Sci. 1986 Mar;75(3):313-6. doi: 10.1002/jps.2600750323. J Pharm Sci. 1986. PMID: 3701619

8

Simultaneous measurement of the cell-differentiating agent hexamethylene bisacetamide and its metabolites by gas chromatography.

Roth JS, Kelley JA, Chun HG, Ward FT. Roth JS, et al. J Chromatogr. 1994 Feb 11;652(2):149-59. doi: 10.1016/0378-4347(93)e0395-7. J Chromatogr. 1994. PMID: 8006099

9

Determination of 2'-beta-fluoro-2',3'-dideoxyadenosine, an experimental anti-AIDS drug, in human plasma by high-performance liquid chromatography.

Roth JS, Ford H Jr, Tanaka M, Mitsuya H, Kelley JA. Roth JS, et al. J Chromatogr B Biomed Sci Appl. 1998 Aug 7;712(1-2):199-210. doi: 10.1016/s0378-4347(98)00144-3. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9698243

10

Determination of lodenosine and its major metabolite in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.

Roth JS, Wang J, Kelley JA. Roth JS, et al. J Mass Spectrom. 2000 Nov;35(11):1313-9. doi: 10.1002/1096-9888(200011)35:11<1313::AID-JMS65>3.0.CO;2-V. J Mass Spectrom. 2000. PMID: 11114090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters